
Nuritas secures $42 million in Series C funding
The funding round included major investments from McWin Capital Partners and M&G Investments.
"McWin Capital Partners are the perfect partners to join us on this journey and help us continue to innovate and grow the business,” said Nora Khaldi, PhD, founder and CEO of Nuritas in a press release. “Their experience working in the food sector and with companies on the cutting edge of innovation will be a huge asset to our team and to the benefit of our customer network. We look forward to the partnership.”
As part of the funding round, Alex Seddon, head of impact and private equity at M&G Investments and Henry McGovern, co-founder of McWin Capital Partners, is joining the Nuritas Board of Directors. “We are proud to lead this round of investment into Nuritas, as they continue to leverage the AI-powered Magnifier platform to discover novel, functional ingredients that will provide broad-based preventative health benefits,” said Seddon, in a press release. “This investment reflects our commitment to supporting scalable solutions that deliver measurable impact. By partnering with Nuritas, we look forward to supporting their groundbreaking work, ultimately advancing sustainable, healthier outcomes for people and the planet.”
"We are thrilled to join Nuritas at this pivotal moment in their journey,” added Martin Davalos, partner and head of food tech at McWin Capital Partners. “Henry McGovern and I bring complementary expertise, and together with the Nuritas team, we are excited to help accelerate their growth. We are passionate about healthier, safer and more sustainable products and believe consumers worldwide should have the right to access these with ease - and Nuritas are at the forefront of developing technology and products to meet that need.”
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.





